- Home
- / Prescient Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Prescient Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-17
Market Capitalization
$35.4 M
2024-10-17
CreditSafe Score
?
Score changed on Jun 14, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| AUD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Gross profit | 939.0K | 1.6M | 1.1M | 1.2M | 1.9M | 2.4M | 3.7M | 4.4M |
| Operating expense total | 3.6M | 5.5M | 4.5M | 5.4M | 7.1M | 9.9M | 10.9M | 11.9M |
| Depreciation and amortization | 1.0K | 1.0K | 1.0K | 1.7M | ||||
| EBITDA | (2.7M) | (3.9M) | (3.4M) | (4.2M) | (5.2M) | (7.5M) | (7.2M) | (7.5M) |
| EBIT | (2.7M) | (3.9M) | (3.4M) | (4.2M) | (5.2M) | (7.5M) | (8.9M) | (7.5M) |
| Interest income | 125.0K | 72.0K | 70.0K | 66.0K | 44.0K | 459.0K | 688.0K | 226.0K |
| Interest expense | 2.0K | 3.0K | 4.0K | 11.0K | 7.0K | |||
| Pre tax profit | (2.6M) | (3.8M) | (3.3M) | (4.1M) | (5.1M) | (7.0M) | (8.2M) | (7.3M) |
| Net Income | (2.6M) | (3.8M) | (3.3M) | (4.1M) | (5.1M) | (7.0M) | (8.2M) | (7.3M) |